Trial intelligence / Profile preview

Bepotastine Besilate Nasal Spray in Seasonal Allergic Rhinitis (EEC Study)

NCT01222299Phase 2Completed

Sponsor
Bausch + Lomb
Start
May 2010
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bepotastine in seasonal allergic rhinitis (SAR), sponsored by Bausch + Lomb. Started May 2010; status: completed.

02

Drugs

bepotastine
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT01222299.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01222299.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call